JAK1 and urothelial carcinoma: The early-onset and aggressive nature of the malignancy, along with the fact that JAK1 is a hotspot for damaging somatic mutations in bladder carcinoma (28), led us to investigate whether impaired JAK1 function may be a specific predisposing factor for urothelial carcinoma.